Company profile
SANUWAVE Health Inc.
NASDAQ: SNWV · Healthcare · Medical - Devices
#450 of 1,417 Healthcare companies by revenuetop-quartile growth
EA Score
74BFH 76DQ 83GM 71SS 38
v0.1 · 65/100 weight · provisional
↑ return on equity, return on assets · ↓ listing tenure, balance-sheet leverage
Methodology →Revenue TTM
$44.3M
Rev growth YoY (TTM)
+22.5%
Net income (FY)
$11.8M
Employees
55
as of 2026-09-16
Market cap
$35.3M
as of 2026-09-16
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$44.1M$44.1M2025
Net income$11.8M$11.8M2025
Operating income$4.9M$4.9M2025
Total assets$37.3M$37.3M2025
Liabilities$35.7M$35.7M2025
Equity$1.6M$1.6M2025
Revenue trend
FY2022 – FY2025 · USD
FY22
FY22
FY23
FY24
FY25
FY25
FY25
FY25
Revenue by segment
Filed disclosures · FY2025
By product
System Revenue98%
Other Revenue1%
Extended Warranty1%
License Fees0%
By geography
Not disclosed.
The read
What is SANUWAVE Health Inc.’s revenue?
SANUWAVE Health Inc. booked $44.1M in FY2025 revenue, growing 44% year over year — faster than most Healthcare companies we track, at a 26.8% net margin.
Peers · Healthcare
Aquestive Therapeutics, Inc.47DCumberland Pharmaceuticals Inc.70BNew York Health Care, Inc.——HOOKIPA Pharma Inc.——Xilio Therapeutics, Inc.38DMedAvail Holdings, Inc.——Neighbors
Hennepin →Key facts
CEOMorgan C. Frank
SectorHealthcare
IndustryMedical - Devices
HeadquartersEden Prairie, MN
ExchangeNASDAQ: SNWV
Employees55
IPO date2024-10-18
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.